Release Date: 15/08/17 11:51 Summary: XEPT Transaction - Completion Update Price Sensitive: No Download Document 38.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%